Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
| (2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
| E1R | C13H16N2O2 | 1301211-78-8 | Details |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG | C12H18O11 | 562043-82-7 | Details |
| 2',5'-Dideoxyadenosine | C10H13N5O2 | 6698-26-6 | Details |
| PF-592379 | C13H21N3O | 710655-15-5 | Details |
| 264W94 | C23H31NO4S | 178961-24-5 | Details |
| Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
| DT-061 | C25H23F3N2O5S | 1809427-19-7 | Details |
| (-)-GSK598809；1S,5R-GSK598809 | C22H23F4N5OS | 863680-46-0 | Details |
| CRTh2 antagonist 1 | C23H25N3O5S | 1379445-54-1 | Details |
| 2614W94 | C15H11F3O4S | 205187-35-5 | Details |
| A2B receptor antagonist 1 | C21H24N6O2 | 531506-36-2 | Details |
| (2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
| (2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
| 3-Carene | C10H16 | 13466-78-9 | Details |
| 3-Bromocytisine | C11H13BrN2O | 207390-14-5 | Details |
| 3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
| 3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
| DPP-IV-IN-1 | C11H18FN3O2 | 625110-37-4 | Details |
| Cephalexin | C16H17N3O4S | 15686-71-2 | Details |
| 20(S)-Hydroxycholesterol | C27H46O2 | 516-72-3 | Details |
| 24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
| (1S,2S,3R)-DT-061 | C25H23F3N2O5S | 1809427-20-0 | Details |
| Estrone | C18H22O2 | 53-16-7 | Details |
| 24-Norursodeoxycholic acid | C23H38O4 | 99697-24-2 | Details |
| 24R-Calcipotriol；PRI 2202 | C27H40O3 | 112827-99-3 | Details |
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride | C11H15ClN2O | 845861-49-6 | Details |
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate | C15H18N2O5 | 78263-91-9 | Details |
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP | C20H24N10O13P2 | 1441190-66-4 | Details |
| (1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| Amoxicillin trihydrate | C16H21N3O6S | 61336-70-7 | Details |
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine | C11H14N2O | 78263-90-8 | Details |
| Neuromuscular Disorder-Targeting Compound 1 | C15H25N3S | 374538-23-5 | Details |
| LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
| 2-Iodomelatonin | C13H15IN2O2 | 93515-00-5 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| 2-Keto-D-Glucose；D-Glucosone | C6H10O6 | 1854-25-7 | Details |
| 3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
| Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
| 3,3'-Diiodo-L-thyronine；3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
| 3,4-Dihydroxybenzylamine hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
| Verapamil hydrochloride | C27H39ClN2O4 | 152-11-4 | Details |
| (2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
| PGS-IN-1 | C19H26O3 | 102271-49-8 | Details |
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium | C7H7O7*3Na | 117041-96-0 | Details |
| 2-Methylcitric acid；Methylcitric acid | C7H10O7 | 6061-96-7 | Details |
| LDL-IN-3 | C24H36O3Si | 180908-67-2 | Details |
| Nanofin | C7H15N | 504-03-0 | Details |
| Propantheline bromide | C23H30BrNO3 | 50-34-0 | Details |
| Thrombin inhibitor 1 | C22H20Cl2F2N4O3 | 855998-46-8 | Details |
| 2',5-Difluoro-2'-deoxycytidine | C9H11F2N3O4 | 581772-30-7 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| 2'-Azido-2'-deoxyuridine；N3dUrd | C9H11N5O5 | 26929-65-7 | Details |
| 2'-Ethyl Simvastatin | C23H34O5 | 79902-42-4 | Details |
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen | C13H18O3 | 51146-55-5 | Details |
| Itraconazole | C35H38Cl2N8O4 | 84625-61-6 | Details |
| 3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
| 3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
| 3-Hydroxy-4-methoxyacetophenone | C9H10O3 | 6100-74-9 | Details |
| 3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
| (3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
| 3-O-Methyltolcapone；Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
| Amikacin | C22H43N5O13 | 37517-28-5 | Details |
| (3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
| (3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
| Acebutolol hydrochloride | C18H29ClN2O4 | 34381-68-5 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| (3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
| 4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
| (3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
| 4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| 4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
| p-Ethynylphenylalanine | C11H11NO2 | 278605-15-5 | Details |
| 4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
| 4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
| 4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
| 4-Bromo A23187；4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
| 3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
| 3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
| 3'-O-Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
| 3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
| 4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
| 4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| VEGFR-2-IN-9；KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
| 3-CPs | C14H10O5 | 20073-24-9 | Details |
| QF0301B | C23H28N2O2 | 149247-12-1 | Details |
| (2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
| Desethyl KBT-3022 | C23H20N2O4S | 101001-72-3 | Details |
| 2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
| MAO-IN-1 | C17H19ClO4 | 124991-40-8 | Details |
| Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
| 3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | ||||